Involvement of human choline kinase alpha and beta in carcinogenesis: A different role in lipid metabolism and biological functions

Advances in Enzyme Regulation

Volumn 51, Issue 1, 2011, Pages 183-194

  Gallego Ortega, David ^a   Gómez del Pulgar, Teresa ^b   Valdés Mora, Fátima ^a   Cebrián, Arancha ^b   Lacal, Juan Carlos ^b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHKA PROTEIN, HUMAN; CHKB PROTEIN, HUMAN; CHOLINE KINASE; ISOENZYME;

AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; MOLECULAR GENETICS; MOUSE; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CHOLINE KINASE; HUMANS; ISOENZYMES; LIPID METABOLISM; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASMS; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 79954565999     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2010.09.010     Document Type: Review

References (97)

1. Aboagye E.O., Bhujwalla Z.M. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999, 59:80-84.
2. Agwu D.E., McPhail L.C., Chabot M.C., Daniel L.W., Wykle R.L., McCall C.E. Choline-linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutrophils. J Biol Chem 1989, 264:1405-1413.
3. Al-Saffar N.M., Jackson L.E., Raynaud F.I., Clarke P.A., Ramírez de Molina A., Lacal J.C., et al. The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy. Cancer Res 2010, 70:5507-5517.
4. Al-Saffar N.M., Troy H., Ramírez de Molina A., Jackson L.E., Madhu B., Griffiths J.R., et al. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. Cancer Res 2006, 66:427-434.
5. Aoyama C., Ishidate K., Sugimoto H., Vance D.E. Induction of choline kinase alpha by carbon tetrachloride (CCl4) occurs via increased binding of c-jun to an AP-1 element. Biochim Biophys Acta 2007, 1771:1148-1155.
6. Aoyama C., Liao H., Ishidate K. Structure and function of choline kinase isoforms in mammalian cells. Prog Lipid Res 2004, 43:266-281.
7. Aoyama C., Nakashima K., Ishidate K. Molecular cloning of mouse choline kinase and choline/ethanolamine kinase: their sequence comparison to the respective rat homologs. Biochim Biophys Acta 1998, 1393:179-185.
8. Aoyama C., Ohtani A., Ishidate K. Expression and characterization of the active molecular forms of choline/ethanolamine kinase-alpha and -beta in mouse tissues, including carbon tetrachloride-induced liver. Biochem J 2002, 363:777-784.
9. Aoyama C., Yamazaki N., Terada H., Ishidate K. Structure and characterization of the genes for murine choline/ethanolamine kinase isozymes alpha and beta. J Lipid Res 2000, 41:452-464.
10. Báñez-Coronel M., Ramírez de Molina A., Rodríguez-González A., Sarmentero J., Ramos M.A., García-Cabezas M.A., et al. Choline kinase alpha depletion selectively kills tumoral cells. Curr Cancer Drug Targets 2008, 8:709-719.
11. Bejanin S., Cervini R., Mallet J., Berrard S. A unique gene organization for two cholinergic markers, choline acetyltransferase and a putative vesicular transporter of acetylcholine. J Biol Chem 1994, 269:21944-21947.
12. Beloueche-Babari M., Chung Y.L., Al-Saffar N.M., Falck-Miniotis M., Leach M.O. Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy. Br J Cancer 2010, 102:1-7.
13. Bhakoo K.K., Williams S.R., Florian C.L., Land H., Noble M.D. Immortalization and transformation are associated with specific alterations in choline metabolism. Cancer Res 1996, 56:4630-4635.
14. Billah M.M., Anthes J.C. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J 1990, 269:281-291.
15. Carman G.M., Kersting M.C. Phospholipid synthesis in yeast: regulation by phosphorylation. Biochem Cell Biol 2004, 82:62-70.
16. Cuadrado A., Carnero A., Dolfi F., Jimenez B., Lacal J.C. Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. Oncogene 1993, 8:2959-2968.
17. Choi M.G., Kurnov V., Kersting M.C., Sreenivas A., Carman G.M. Phosphorylation of the yeast choline kinase by protein kinase C. Identification of Ser25 and Ser30 as major sites of phosphorylation. J Biol Chem 2005, 280:26105-26112.
18. Chua B.T., Gallego-Ortega D., Ramirez de Molina A., Ullrich A., Lacal J.C., Downward J. Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells. Mol Cancer 2009, 8:131.
19. Chung T., Huang J.S., Mukherjee J.J., Crilly K.S., Kiss Z. Expression of human choline kinase in NIH 3T3 fibroblasts increases the mitogenic potential of insulin and insulin-like growth factor I. Cell Signal 2000, 12:279-288.
20. de Certaines J.D., Larsen V.A., Podo F., Carpinelli G., Briot O., Henriksen O. In vivo 31P MRS of experimental tumours. NMR Biomed 1993, 6:345-365.
21. Eliyahu G., Kreizman T., Degani H. Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int J Cancer 2007, 120:1721-1730.
22. Erickson J.D., Varoqui H., Schafer M.K., Modi W., Diebler M.F., Weihe E., et al. Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J Biol Chem 1994, 269:21929-21932.
23. Gallego-Ortega D., Ramirez De Molina A., Gutierrez R., Ramos M.A., Sarmentero J., Cejas P., et al. Generation and characterization of monoclonal antibodies against choline kinase alpha and their potential use as diagnostic tools in cancer. Int J Oncol 2006, 29:335-340.
24. Gallego-Ortega D., Ramirez de Molina A., Ramos M.A., Valdes-Mora F., Barderas M.G., Sarmentero-Estrada J., et al. Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment. PLoS One 2009, 4:e7819.
25. Glunde K., Raman V., Mori N., Bhujwalla Z.M. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. Cancer Res 2005, 65:11034-11043.
26. Glunde K., Serkova N.J. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. Pharmacogenomics 2006, 7:1109-1123.
27. Glunde K., Shah T., Winnard P.T., Raman V., Takagi T., Vesuna F., et al. Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model. Cancer Res 2008, 68:172-180.
28. Hamza M., Lloveras J., Ribbes G., Soula G., Douste-Blazy L. An in vitro study of hemicholinium-3 on phospholipid metabolism of Krebs II ascites cells. Biochem Pharmacol 1983, 32:1893-1897.
29. Hernández-Alcoceba R., Fernández F., Lacal J.C. In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery. Cancer Res 1999, 59:3112-3118.
30. Hernández-Alcoceba R., Saniger L., Campos J., Núñez M.C., Khaless F., Gallo M.A., et al. Choline kinase inhibitors as a novel approach for antiproliferative drug design. Oncogene 1997, 15:2289-2301.
31. Hernando E., Sarmentero-Estrada J., Koppie T., Belda-Iniesta C., Ramírez de Molina V., Cejas P., et al. A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas. Oncogene 2009, 28:2425-2435.
32. Hong B.S., Allali-Hassani A., Tempel W., Finerty P.J., Mackenzie F., Dimov S., et al. Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivity. J Biol Chem 2010, 285:16330-16340.
33. Hundertmark S., Lorenz U., Weitzel H.K., Ragosch V. Effect of epidermal growth factor on enzymes of phospholipid biosynthesis in lung and liver of fetal rat in vivo and in vitro. Horm Metab Res 1999, 31:8-13.
34. Iorio E., Mezzanzanica D., Alberti P., Spadaro F., Ramoni C., D'Ascenzo S., et al. Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res 2005, 65:9369-9376.
35. Iorio E., Ricci A., Bagnoli M., Pisanu M.E., Castellano G., Di Vito M., et al. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res 2010, 70:2126-2135.
36. Ishidate K., Tsuruoka M., Nakazawa Y. Induction of choline kinase by polycyclic aromatic hydrocarbon carcinogens in rat liver. Biochem Biophys Res Commun 1980, 96:946-952.
37. Janardhan S., Srivani P., Sastry G.N. Choline kinase: an important target for cancer. Curr Med Chem 2006, 13:1169-1186.
38. Jiménez B., del Peso L., Montaner S., Esteve P., Lacal J.C. Generation of phosphorylcholine as an essential event in the activation of Raf-1 and MAP-kinases in growth factors-induced mitogenic stimulation. J Cell Biochem 1995, 57:141-149.
39. Katz-Brull R., Lavin P.T., Lenkinski R.E. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002, 94:1197-1203.
40. Kennedy E.P. Metabolism of lipides. Annu Rev Biochem 1957, 26:119-148.
41. Kenny L.M., Contractor K.B., Hinz R., Stebbing J., Palmieri C., Jiang J., et al. Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab. Clin Cancer Res 2010, 16:4236-4245.
42. Kent C. Regulation of phosphatidylcholine biosynthesis. Prog Lipid Res 1990, 29:87-105.
43. Kim K.H., Carman G.M. Phosphorylation and regulation of choline kinase from Saccharomyces cerevisiae by protein kinase A. J Biol Chem 1999, 274:9531-9538.
44. Kiss Z., Chung T. Choline phosphate and phorbol ester potentiate the mitogenic effect of insulin by competitive mechanisms in NIH 3T3 fibroblasts. Biochem Biophys Res Commun 1996, 218:505-509.
45. Ko K.W., Cook H.W., Vance D.E. Reduction of phosphatidylcholine turnover in a Nb 2 lymphoma cell line after prolactin treatment. A novel mechanism for control of phosphatidylcholine levels in cells. J Biol Chem 1986, 261:7846-7852.
46. Krishnamachary B., Glunde K., Wildes F., Mori N., Takagi T., Raman V., et al. Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft. Cancer Res 2009, 69:3464-3471.
47. Lacal J.C. Diacylglycerol production in Xenopus laevis oocytes after microinjection of p21ras proteins is a consequence of activation of phosphatidylcholine metabolism. Mol Cell Biol 1990, 10:333-340.
48. Lacal J.C. Choline kinase: a novel target for antitumor drugs. IDrugs 2001, 4:419-426.
49. Lacal J.C., Moscat J., Aaronson S.A. Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene. Nature 1987, 330:269-272.
50. Macara I.G. Elevated phosphocholine concentration in ras-transformed NIH 3T3 cells arises from increased choline kinase activity, not from phosphatidylcholine breakdown. Mol Cell Biol 1989, 9:325-328.
51. Malito E., Sekulic N., Too W.C., Konrad M., Lavie A. Elucidation of human choline kinase crystal structures in complex with the products ADP or phosphocholine. J Mol Biol 2006, 364:136-151.
52. Man A.S., Lee E., Choy P.C. Biphasic modulation of choline uptake and phosphatidylcholine biosynthesis by vasopressin in rat cardiac myocytes. Lipids 1994, 29:15-19.
53. Millington W.R., Wurtman R.J. Choline administration elevates brain phosphorylcholine concentrations. J Neurochem 1982, 38:1748-1752.
54. Moolenaar W.H., Kruijer W., Tilly B.C., Verlaan I., Bierman A.J., de Laat S.W. Growth factor-like action of phosphatidic acid. Nature 1986, 323:171-173.
55. Mori N., Glunde K., Takagi T., Raman V., Bhujwalla Z.M. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells. Cancer Res 2007, 67:11284-11290.
56. Nakagami K., Uchida T., Ohwada S., Koibuchi Y., Morishita Y. Increased choline kinase activity in 1,2-dimethylhydrazine-induced rat colon cancer. Jpn J Cancer Res 1999, 90:1212-1217.
57. Nakagami K., Uchida T., Ohwada S., Koibuchi Y., Suda Y., Sekine T., et al. Increased choline kinase activity and elevated phosphocholine levels in human colon cancer. Jpn J Cancer Res 1999, 90:419-424.
58. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992, 5:303-324.
59. Nimmagadda S., Glunde K., Pomper M.G., Bhujwalla Z.M. Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells. Neoplasia 2009, 11:477-484.
60. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992, 258:607-614.
61. Paddon H.B., Vigo C., Vance D.E. Diethylstilbestrol treatment increases the amount of choline kinase in rooster liver. Biochim Biophys Acta 1982, 710:112-115.
62. Pelech S.L., Vance D.E. Regulation of phosphatidylcholine biosynthesis. Biochim Biophys Acta 1984, 779:217-251.
63. Porter T.J., Kent C. Purification and characterization of choline/ethanolamine kinase from rat liver. J Biol Chem 1990, 265:414-422.
64. Pritchard P.H., Vance D.E. Choline metabolism and phosphatidylcholine biosynthesis in cultured rat hepatocytes. Biochem J 1981, 196:261-267.
65. Rameh L.E., Cantley L.C. The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 1999, 274:8347-8350.
66. Ramírez de Molina A., Báñez-Coronel M., Gutiérrez R., Rodríguez-González A., Olmeda D., Megías D., et al. Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression. Cancer Res 2004, 64:6732-6739.
67. Ramírez de Molina A., Gallego-Ortega D., Sarmentero J., Báñez-Coronel M., Martin-Cantalejo Y., Lacal J.C. Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis. Cancer Res 2005, 65:5647-5653.
68. Ramírez de Molina A., Gutiérrez R., Ramos M.A., Silva J.M., Silva J., Bonilla F., et al. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy. Oncogene 2002, 21:4317-4322.
69. Ramírez de Molina A., Penalva V., Lucas L., Lacal J.C. Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K. Oncogene 2002, 21:937-946.
70. Ramírez de Molina A., Rodríguez-González A., Gutiérrez R., Martínez-Piñeiro L., Sánchez J., Bonilla F., et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun 2002, 296:580-583.
71. Ramírez de Molina A., Rodríguez-González A., Penalva V., Lucas L., Lacal J.C. Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells. Biochem Biophys Res Commun 2001, 285:873-879.
72. Ramírez de Molina A., Sarmentero-Estrada J., Belda-Iniesta C., Taron M., Ramírez de Molina V., Cejas P., et al. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. Lancet Oncol 2007, 8:889-897.
73. Ratnam S., Kent C. Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines. Arch Biochem Biophys 1995, 323:313-322.
74. Rodríguez-González A., Ramírez de Molina A., Báñez-Coronel M., Megías D., Lacal J.C. Inhibition of choline kinase renders a highly selective cytotoxic effect in tumour cells through a mitochondrial independent mechanism. Int J Oncol 2005, 26:999-1008.
75. Rodríguez-González A., Ramírez de Molina A., Benítez-Rajal J., Lacal J.C. Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets. Prog Cell Cycle Res 2003, 5:191-201.
76. Rodríguez-González A., Ramírez de Molina A., Fernández F., Ramos M.A., del Carmen Núñez M., Campos J., et al. Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells. Oncogene 2003, 22:8803-8812.
77. Ruiz-Cabello J., Cohen J.S. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 1992, 5:226-233.
78. Ruiz-Cabello J., Cohen J.S. NMR and the study of pathological state in cells and tissues. Int Rev Cytol 1993, 145:1-63.
79. Shah T., Wildes F., Penet M.F., Winnard P.T., Glunde K., Artemov D., et al. Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells. NMR Biomed 2010, 23:633-642.
80. Sher R.B., Aoyama C., Huebsch K.A., Ji S., Kerner J., Yang Y., et al. A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis. J Biol Chem 2006, 281:4938-4948.
81. Smith T.A., Bush C., Jameson C., Titley J.C., Leach M.O., Wilman D.E., et al. Phospholipid metabolites, prognosis and proliferation in human breast carcinoma. NMR Biomed 1993, 6:318-323.
82. Tadokoro K., Ishidate K., Nakazawa Y. Evidence for the existence of isozymes of choline kinase and their selective induction in 3-methylcholanthrene- or carbon tetrachloride-treated rat liver. Biochim Biophys Acta 1985, 835:501-513.
83. Teegarden D., Taparowsky E.J., Kent C. Altered phosphatidylcholine metabolism in C3H10T1/2 cells transfected with the Harvey-ras oncogene. J Biol Chem 1990, 265:6042-6047.
84. Tso P., Fujimoto K. The absorption and transport of lipids by the small intestine. Brain Res Bull 1991, 27:477-482.
85. Uchida T. Regulation of choline kinase R: analyses of alternatively spliced choline kinases and the promoter region. J Biochem 1994, 116:508-518.
86. Uchida T. Stimulation of phospholipid synthesis in HeLa cells by epidermal growth factor and insulin: activation of choline kinase and glycerophosphate acyltransferase. Biochim Biophys Acta 1996, 1304:89-104.
87. Uchida T., Yamashita S. Molecular cloning, characterization, and expression in Escherichia coli of a cDNA encoding mammalian choline kinase. J Biol Chem 1992, 267:10156-10162.
88. Upreti R.K. Influence of choline and ethanolamine administration on choline and ethanolamine phosphorylating activities of mouse liver and kidney. Can J Biochem 1979, 57:981-985.
89. Vance D.E., Choy P.C. How is phosphatidylcholine biosynthesis regulated?. Trends Biochem Sci 1979, 4:145-148.
90. Warden C.H., Friedkin M. Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. J Biol Chem 1985, 260:6006-6011.
91. Wu G., Aoyama C., Young S.G., Vance D.E. Early embryonic lethality caused by disruption of the gene for choline kinase alpha, the first enzyme in phosphatidylcholine biosynthesis. J Biol Chem 2008, 283:1456-1462.
92. Wu G., Sher R.B., Cox G.A., Vance D.E. Differential expression of choline kinase isoforms in skeletal muscle explains the phenotypic variability in the rostrocaudal muscular dystrophy mouse. Biochim Biophys Acta 2010, 1801:446-454.
93. Yalcin A., Clem B., Makoni S., Clem A., Nelson K., Thornburg J., et al. Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling. Oncogene 2010, 29:139-149.
94. Yamazaki N., Shinohara Y., Kajimoto K., Shindo M., Terada H. Novel expression of equivocal messages containing both regions of choline/ethanolamine kinase and muscle type carnitine palmitoyltransferase I. J Biol Chem 2000, 275:31739-31746.
95. Yamazaki N., Yamanaka Y., Hashimoto Y., Shinohara Y., Shima A., Terada H. Structural features of the gene encoding human muscle type carnitine palmitoyltransferase I. FEBS Lett 1997, 409:401-406.
96. Zeisel S.H. Choline phospholipids: signal transduction and carcinogenesis. FASEB J 1993, 7:551-557.
97. Zeisel S.H., Da Costa K.A., Franklin P.D., Alexander E.A., Lamont J.T., Sheard N.F., et al. Choline, an essential nutrient for humans. FASEB J 1991, 5:2093-2098.